SmartHealth

17_smarthealth

CarThera starts phase I/II trial in collaboration with Northwestern University to test SonoCloud-9 in patients with recurrent glioblastoma

NIH funded clinical trial explores combination of SonoCloud-9 device with Abraxane®; first patient treated and recruitment now on-going CarThera, a French company that designs and develops innovative ultrasound-based medical devices to treat brain disorders, today announces the launch of a new phase I/II clinical trial (NCT04528680) in collaboration with Northwestern University in Chicago. The trial…
15_smarthealth

Machine Learning Predicts Which Breast Cancer Patients Need Surgery

The machine learning tool could help breast cancer patients avoid unnecessary treatment and reduce healthcare costs A machine learning algorithm can analyze medical images and predict which breast cancer patients need surgery, revealed a study published in the American Journal of Physiology – Cell Physiology. Ductal carcinoma in situ (DCIS) of the breast – also…
14_smarthealth

Siemens Healthineers and IBM are working together to Digitally Network the Healthcare System in Germany

In the future, the platform will be available for third parties to add new, innovative apps and digital solutions and make them available to the healthcare industry Siemens Healthineers and IBM Deutschland are introducing an open digital platform that will advance the networking of the German healthcare system and expand the infrastructure for the provision…
08_smarthealth

Oxford University Hospitals Achieves Technology Accreditation

The Nuffield Orthopaedic Centre (NOC) in Oxford has been rated highly for how it uses technology to improve patient care. Oxford University Hospitals NHS Foundation Trust, which runs the hospital, has reached 'Stage 6' on the EMR Adoption and Maturity (EMRAM) scale, the second highest rating by the international Healthcare Information and Management Systems Society…
01_smarthealth

Big Data Powers Design of ‘Smart’ Cell Therapies for Cancer

To program these instructions into T cells, they used a system known as synNotch, a customizable molecular sensor that allows synthetic biologists to fine-tune the programming of cells Finding medicines that can kill cancer cells while leaving normal tissue unscathed is a Holy Grail of oncology research. In two new papers, scientists at UC San…
24_smarthealthingl

About 300 medical organizations in Moscow use AI

About 300 medical organizations in Moscow are already using artificial intelligence to diagnose various diseases based on the results of X-ray studies. 21 companies have offered their services (38 solutions in total) in the field of artificial intelligence. Artificial intelligence integrated into the UMIAS radiology information service analyzes several types of radiology examinations - computed…
16_smarthealth

Central Hospital in Finland Automates Symptom Tracking of Coronavirus-Infected Patients’ with Help of an App

The mobile application and remote patient monitoring dashboard bring peace of mind to the patients as they know that their well-being and symptoms are being monitored every day This November Central Ostrobothnia Central Hospital in Finland has started symptom tracking and remote monitoring of corona virus-infected patients with the Buddy Healthcare mobile application and clinical…
12_smarthealth

Technology Companies Partner to Accelerate New Remote Homecare Services in Response to COVID-19

Develco Products and People Power deliver white label AI-powered solutions for rapidly expanding homecare market Develco Products A/S, a business-to-business wireless technology leader providing state-of-the-art IoT gateways and connected devices headquartered Aarhus, Denmark, announces a strategic partnership with People Power, a Silicon-Valley based software and services company. Advanced hardware from Develco Products combined with People…
05-Smarthealt

Saillant Therapeutics Reports Proof of Concept of its Treatment in Heart Failure Showing Functional Reversal and Myocardial Rejuvenation

Using a heart failure animal model found out that the new treatment restored heart function in failing hearts after four weeks of treatment. Saillant Therapeutics, an innovative preclinical stage biotechnology company developing promising small molecule-based therapies, today announced that it has obtained Proof of Concept for its lead compound (ST02) indicated for the treatment of…
02_smarthealt

Healthcare App Reduces Symptoms of COPD Compared to Regular Treatment

The number of further exacerbations within the group using the app was nearly half that for those who just received treatment as usual. COPD is a common respiratory condition and one of the top causes of hospital admissions each year, particularly during winter months. In the UK it accounts for over 140,000 hospital admissions and…

Latest News